About Theralase Technologies
Theralase Technologies is a publicly listed company based in Toronto (Canada) founded in 1994. Super pulsed cold laser technology for musculoskeletal pain. Its focus areas include Life Sciences, Pain Management, Medical Devices and Therapeutic Devices. Its legal entity is THERALASE TECHNOLOGIES INC /FI.
Company details
Theralase Technologies Inc. designs, develops and manufactures super-pulsed, cold laser technology for a wide range of human, companion animal and equine applications.Some applications include treatment of pain, reducing inflammation, treating musculo-skeletal conditions, wounds, and nerves. The technology can be used to treat tissues within 4 inches from the skin surface.
- Headquarters Toronto, Canada
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website theralase.com
- Social LinkedIn X Facebook
- Legal Name Theralase Technologies Inc.
- Annual Revenue$596.32 K (USD)-20.99as on Dec 31, 2025
- Net Profit-$3.01 M (USD)3.18as on Dec 31, 2025
- EBITDA-$2.86 M (USD)2.65as on Dec 31, 2025
- Latest Funding Round$109.08K (USD), Post-IPO
May 2026
Funding Insights of Theralase Technologies
- Total Rounds 10
- Last Round Post-IPO — $109,080
- First Round $62,622
(May 2018)
All 10 funding rounds of Theralase Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2026 | $109,080 | Post-IPO | – | – | – |
| Nov 2024 | $475,285 | Post-IPO | – | – | – |
| Apr 2024 | $548,140 | Post-IPO | – | – | – |
| Nov 2023 | $860,904 | Post-IPO | – | – | – |
| Sep 2023 | $346,061 | Post-IPO | – | – | – |
| Nov 2022 | $188,077 | Post-IPO | – | – | – |
| Sep 2022 | $1.87M | Post-IPO | – | – | – |
| Sep 2019 | $323,489 | Post-IPO | – | – | – |
| Oct 2018 | $160,109 | Post-IPO | – | – | – |
| May 2018 | $62,622 | Post-IPO | – | – | – |
IPO & Listings of Theralase Technologies
Theralase Technologies is a publicly listed company on the TSXV with ticker symbol TLT in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Nov 2004
- Listed onTSX-V: TLT
- Listed entityTheralase Technologies Inc.
- Exchange sectorHealth technology
- ISINCA88337V1004
- Share price0.18 CAD (+2.86% on the day) · 2026-10-13
- Market capitalisation55,886,997.00 CAD
- EPS (diluted, trailing year)-0.01 CAD
- Volume (last session)184,605
Financials of Theralase Technologies
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 816,470 CAD | -4.1M CAD | -3.9M CAD |
| 2024 | 1.0M CAD | -4.3M CAD | -4.0M CAD |
| 2023 | 1.1M CAD | -4.6M CAD | -4.3M CAD |
| 2022 | 1.1M CAD | -5.2M CAD | -5.1M CAD |
| 2021 | 780,640 CAD | -4.4M CAD | -4.5M CAD |
Detailed financial statements for Theralase Technologies
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Theralase Technologies
4 dated milestones of Theralase Technologies across 32 years, from founding to its latest funding, stage changes and deals.
- Founded Theralase Technologies is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $63K.
- Funding Latest funding round, Post-IPO, of $109K.
Web traffic of Theralase Technologies
The website of Theralase Technologies (theralase.com) receives about 9.5K visits a month.
- Monthly visits9.5K
▲ 55.1% vs previous month
Websites whose visitors overlap most with Theralase Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
leisegang.com | leisegang.com | 100% | – | ||
bioland.com.hk | bioland.com.hk | 77% | – | ||
medikraft.com | medikraft.com | 77% | – | ||
chinamedica.com | chinamedica.com | 77% | #14,416,122 | – | |
oxymist.com | oxymist.com | 77% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 18 similar websites and full traffic analytics for Theralase Technologies
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Theralase Technologies
Complete news archive for Theralase Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Theralase Technologies
Theralase Technologies was founded in 1994 and raised its 1st funding round 24 years after it was founded.
Theralase Technologies is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Annual revenue of Theralase Technologies is $596.32K as on Dec 31, 2025.
Theralase Technologies Inc. designs, develops and manufactures super-pulsed, cold laser technology for a wide range of human, companion animal and equine applications.Some applications include treatment of pain, reducing inflammation, treating musculo-skeletal conditions, wounds, and nerves. The technology can be used to treat tissues within 4 inches from the skin surface.
Yes, Theralase Technologies is publicly traded on TSXV under the ticker symbol TLT.
Theralase Technologies operates through Theralase Technologies Inc /Fi.